Original document(23 pages)  中文版
    HBsAg can be produced by cultivating yeast containing a recombinant DNA wherein a DNA in which a sequence complementary with the 3' end of 18S ribosomal RNA is added upstream of a DNA coding for hepatit is B virus surface antigen is bound just after a sequence complementary with the 3' end of 18S ribosomal RNA located at the 5' non-coding region of yeast repressible acid phosphatase gene. HBsAg thus obtained can be used as a vaccine to prevent HBV infection.
Application Number
申请号
85107120 Application Date
申请日
1985.09.21
Title 名称 Recombinant DNA and use thereof
Publication Number
公开号
1009927 Publication Date
公开日
1987.04.01
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K39/29,C12N1/18,C12N15/00
Applicant(s) Name
申请人
Takeda Chemical Industries, Ltd. (JP) Osaka 541, Japan
Address 地址
Inventor(s) Name 发明人 Masakazu Kikuchi
Attorney & Agent 代理人 LUO HONG LIU YUANJIN
More information 更  多  信  息


 Related patents information
Hepatitis B virus surface antigen and production thereof
Production of human lysozyme
Production of human lysozyme
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.